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Introduction
Endometrial cancer is the most common gynecological malignant neoplasm, and its standard treatment is surgical removal of the uterus. Total abdominal hysterectomy and bilateral salpingooophorectomy with or without bilateral pelvic/para-aortic lymphadenectomy has been the standard surgery for early stage endometrial cancer. However, recent advances in laparoscopic surgery have enabled it to be utilized for the treatment of early stage endometrial cancer as a less invasive surgical option than laparotomy. Most previous studies that compared laparoscopic surgery to laparotomy showed a comparable or significantly lower incidence of treatment-related morbidity, a shorter hospital stay, less blood loss, less pain, and a faster recovery with the laparoscopic approach. 1 For this reason, we have also adopted laparoscopic surgery for the treatment of early stage endometrial cancer. While extrafascial hysterectomy is usually recommended to remove the uterus thoroughly, we have chosen total laparoscopic modified radical hysterectomy (TLmRH; equivalent to Piver-
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Rutledge class II hysterectomy) as a highly effective procedure to reduce the risk of vaginal recurrence after surgery. We included the operated cases with or without lymphadenectomy in order to investigate the feasibility of these procedures comprehensively.
Aim
The aim of this study was to assess the safety of TLmRH, because very few studies describing this technique have been reported thus far.
Materials and Methods
We retrospectively reviewed the operated cases with endometrial cancer at the Department of Gynecology, Yokohama City University Medical Center, Yokohama, Japan between December 2011 and September 2015. General consent was obtained from all patients preoperatively, and the Yokohama City University Medical Center Institutional Ethics Committee approved this study. Preoperative histological diagnosis was made via uterine cavity curettage. The extent of muscle invasion was based on preoperative examination using enhanced magnetic resonance imaging. Metastases were evaluated with computed tomography (CT) scan. TLmRH þ bilateral salpingo-oophorectomy (BSO) þ pelvic lymphadenectomy (PLA) þ para-aortic lymphadenectomy (PALA) was undertaken fundamentally for the patients with endometrial cancer. It has been reported that para-aortic lymph node metastasis was found to be 10e17% in the endometrial cancer when muscle invasion was > 50%. 2e4 It has also been reported that PALA is not necessary when cytological examination is negative and pelvic lymph node metastasis is not found by pelvic lymphadenectomy. 5 Based on these observations, PALA was excluded and TLmRH þ BSO þ PLA was undertaken for patients with Grade 1 endometrioid cancer when superficial muscle invasion was suspected to be < 50%. Because it has been reported that lymph node metastasis is seen in only 1e2% of endometrial cancer patients when muscle invasion is not found, 6,7 lymphadenectomy was excluded and TLmRH þ BSO was undertaken for patients with Grade 1 endometrioid cancer with no obvious muscle invasion. Data are expressed as median (range) or n (%). BMI ¼ body mass index; PALA ¼ para-aortic lymphadenectomy, PLA ¼ pelvic lymphadenectomy; TLmRH ¼ total laparoscopic modified radical hysterectomy. In cases where PALA was performed, this procedure was undertaken through the retroperitoneal cavity, followed by TLmRH and PLA. When PLA and/or PALA was excluded, we diagnosed the stage of patients clinically using preoperative CT scan.
The surgical procedure for TLmRH, equivalent to PivereRutledge class II hysterectomy, was as follows: patients were under endotracheal general anesthesia in a modified dorso-lithotomy position. To prevent the scattering of cancer cells to the vagina, a cervical cuff was made to cover the external os of the uterus transvaginally prior to the laparoscopic surgery. We used a five-port technique without intrauterine manipulation. The initial 12-mm umbilical port was inserted and the abdomen was insufflated with carbon dioxide (10 mmHg). Three additional 5-mm trocars were inserted in the right, left, and medial part of the lower abdomen at the level of the anterior superior iliac spine. Another 5 mm trocar was inserted under the left costal arch to retract the uterus with grasping forceps. After collecting peritoneal washings for cytologic examination, the bilateral tubes were coagulated with bipolar forceps to prevent scattering of cancer cells to the peritoneal cavity. After opening the vesicouterine peritoneum, the round ligament was cut with an ENSEAL tissue sealer (Ethicon Endo-Surgery, Cincinnati, OH, USA). The uterine arteries and the ureters were identified and the uterine arteries were ligated and cut. The vesicouterine, infundibulopelvic, and uterosacral ligaments were transected. The paracolpium was ligated and resected, then circumferential colpotomy was performed on the rim of the Vagi-pipe (Hakko, Chikuma, Japan). The uterus and adnexa were removed through the vagina and the vaginal vault was sutured laparoscopically. The operation was completed by placing a drain on the pouch of Douglas.
We analyzed the characteristics and surgical outcomes of our patients and compared them to previously reported results.
Results
Forty-nine patients who underwent TLmRH were included; of these, 20 underwent TLmRH þ BSO, 18 underwent TLmRH þ BSO þ PLA, and 11 underwent TLmRH þ BSO þ PLA þ PALA. The characteristics of the patients and surgical results are summarized in Table 1 . The median age was 57 years (range, 39e77 years), the median body mass index was 23.7 kg/m 2 (range, 17.7e39.4 kg/m 2 ), and 24.5% of our patients had previous abdominal surgery. The postoperative histological diagnosis of the majority of patients was Grade 1 or 2 endometrioid carcinoma (43 cases, 88%). The staging of the majority of patients was FIGO 1A (90%). The median operative time was 204 minutes (range, 99e504 minutes), and the median intraoperative blood loss was 150 mL (range, 0e680 mL). None of the patients needed a blood transfusion, conversion to laparotomy, or reoperation. The mean length of vaginal wall that was removed with the uterus was 20.0 mm (range, 10.0e27.5 mm).
Intraoperative complications were observed in three patients and included bladder, nerve, and ureter injury. The bladder injury occurred during the TLmRH procedure and was managed laparoscopically. The obturator nerve injury was observed during the PLA procedure and was fixed laparoscopically. The ureter injury occurred during the PALA procedure and required the indwelling of a urethral stent for 3 months after surgery. Postoperative complications were seen in nine patients (Table 1) .
We compared these results to previous reports 1,8e13 that studied patients who underwent laparoscopic hysterectomy for endometrial cancer (Table 2) . We found that the operative time was longer in our study (median, 204 minutes) than in others (75e204 minutes). The hospital stay after surgery also tended to be longer in our study (6 days) than in others (2e4 days). However, blood loss (150 mL vs. 100e171 mL), the incidence of intraoperative complications (6.1% vs. 0e10.8%), and the incidence of We also compared our results to previous reports 14, 15 that studied patients who received TLmRH with or without PLA for endometrial cancer or cervical cancer (Table 3) . We found that the estimated blood loss tended to be greater in our study than in others and the operative time was equivalent. The patients were followed every 2e3 months for first 1e2 years and every 4e6 months thereafter for 5 years with bimanual examination, Papanicolaou smear of vaginal stump, ultrasonography, and serum CA125. Examination with CT scan is occasionally adopted. The median follow-up was 673 days (range, 97e1639 days). During the follow-up period, one patient of stage 1A, G1 who underwent TLmRH þ BSO had peritoneal metastasis 4 months after the surgery. However, she obtained complete remission with chemotherapy. As of the latest follow-up, all patients were doing well and showed no signs of recurrence.
Discussion
The present study revealed that TLmRH is a feasible and safe procedure for the treatment of early stage endometrial cancer. When we compared our results to those in previously reported studies of patients treated with total laparoscopic hysterectomy (TLH), 1,8e13 we tended to need more operating time. However, this is partly because our procedure also included the time needed to make the cervical cuff prior to the laparoscopic surgery and the time needed for the lymphadenectomies. The postoperative hospital stay also tended to be longer in this study. Although no study has compared the hospital stay length between Japan and Western countries, operated patients seem to have tendency to stay in the hospital longer in Japan compared to Western countries. For instance, in the studies that compare laparotomic and laparoscopic mRH, Terai et al 14 reported that mean days of hospital stay were 14.6 ± 12.6 and 9.3 ± 2.5, respectively, in a Japanese hospital. By contrast, Ditto et al 15 reported that median hospital stays were 6 days (3e14 days) and 4 days (3e11 days), respectively, in an Italian hospital. These differences may be the reason for the results, which showed longer postoperative hospital stay in this study.
When we compared our cases to those previously treated with TLmRH, the estimated blood loss tended to be greater. The reason for this is uncertain; however, it does not seem to be remarkable. Aside from these observations, our results are comparable with previous studies. 14, 15 In this study, transfusion, conversion to surgical staging can be performed with similar overall survival, and relatively small differences were observed in recurrence rates 19 in the patients with endometrial cancer treated with laparoscopy, compared with those treated with laparotomy. TLH is the current standard procedure for removing the uterus laparoscopically. However, a risk of this procedure is the failure to accomplish the extrafascial procedure fully, resulting in a small part of the uterine cervix remaining. Han et al 20 compared laparotomic mRH and extrafascial hysterectomy in the treatment of stage I endometrial cancer and they could not see the statistical difference in recurrence rate and 5-year disease-free survival between them. However, they reported that further studies using larger sample sizes were needed because the different recurrence rate and 5-year disease-free survival that might show the superiority of mRH were observed in their small number of study population. Signorelli et al 21 also compared laparotomic mRH and extrafascial hysterectomy in the treatment of stage I endometrial cancer. They concluded that mRH did not improve locoregional control and survival compared to class I or extrafascial hysterectomy; however, mRH allows optional vaginal and pelvic control of disease with a 22 TLmRH may help to reduce this rate, although further studies are needed to demonstrate the advantage of TLmRH over TLH.
In conclusion, TLmRH is safe and feasible for the treatment of early stage endometrial cancer. This procedure can be an alternative to TLH, especially in cases where the uterus must be removed completely.
